Trial Profile
Dose response of inhaled tacrolimus in patients with moderate persistent asthma
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 09 Jun 2014
Price :
$35
*
At a glance
- Drugs Tacrolimus (Primary)
- Indications Asthma
- Focus Therapeutic Use
- Sponsors Astellas Pharma
- 26 Sep 2006 Status change
- 05 Nov 2005 New trial record.